Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1972 1
1980 1
1981 1
1985 2
1986 1
1993 1
1998 1
1999 1
2001 1
2002 2
2003 1
2004 1
2005 4
2006 6
2007 6
2008 4
2009 5
2010 4
2011 6
2012 5
2013 14
2014 20
2015 20
2016 22
2017 26
2018 36
2019 31
2020 24
2021 38
2022 40
2023 59
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

350 results

Results by year

Filters applied: . Clear all
Page 1
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Hagström E, Steg PG, Szarek M, Bhatt DL, Bittner VA, Danchin N, Diaz R, Goodman SG, Harrington RA, Jukema JW, Liberopoulos E, Marx N, McGinniss J, Manvelian G, Pordy R, Scemama M, White HD, Zeiher AM, Schwartz GG; ODYSSEY OUTCOMES Investigators. Hagström E, et al. Circulation. 2022 Aug 30;146(9):657-672. doi: 10.1161/CIRCULATIONAHA.121.057807. Epub 2022 Jun 30. Circulation. 2022. PMID: 35770629 Free PMC article. Clinical Trial.
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.
Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators. Ray KK, et al. Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5. Epub 2019 Jul 1. Lancet Diabetes Endocrinol. 2019. PMID: 31272931 Free article. Clinical Trial.
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.
Schwartz GG, Szarek M, Bittner VA, Diaz R, Goodman SG, Jukema JW, Landmesser U, López-Jaramillo P, Manvelian G, Pordy R, Scemama M, Sinnaeve PR, White HD, Gabriel Steg P; ODYSSEY Outcomes Committees and Investigators. Schwartz GG, et al. J Am Coll Cardiol. 2021 Aug 3;78(5):421-433. doi: 10.1016/j.jacc.2021.04.102. J Am Coll Cardiol. 2021. PMID: 34325831 Free PMC article. Clinical Trial.
Exfoliation of MoS2 Quantum Dots: Recent Progress and Challenges.
Ali L, Subhan F, Ayaz M, Hassan SSU, Byeon CC, Kim JS, Bungau S. Ali L, et al. Among authors: ayaz m. Nanomaterials (Basel). 2022 Oct 4;12(19):3465. doi: 10.3390/nano12193465. Nanomaterials (Basel). 2022. PMID: 36234593 Free PMC article. Review.
Uptake and Accumulation of Nano/Microplastics in Plants: A Critical Review.
Azeem I, Adeel M, Ahmad MA, Shakoor N, Jiangcuo GD, Azeem K, Ishfaq M, Shakoor A, Ayaz M, Xu M, Rui Y. Azeem I, et al. Among authors: ayaz m. Nanomaterials (Basel). 2021 Nov 2;11(11):2935. doi: 10.3390/nano11112935. Nanomaterials (Basel). 2021. PMID: 34835700 Free PMC article. Review.
350 results